Matching process We used a propensity score matching (PSM) method to compare the new users of GLP-1RAs with new users of SGLT2 inhibitors, metformin and other second- or third-line glucose-lowering drugs
The duration varies considerably between individuals and often correlates with dose titration phases and gastrointestinal symptoms
Rajaram S, Baylink DJ, Mohan S
Prescribing Information: Contrave (naltrexone HCl and bupropion HCl extendedrelease)
The FDA could view the wide-scale manufacturing of custom medications as taking advantage of loopholes that ought to be closed: I suspect the FDA never contemplated that [its guidance] would be applied the way it's being applied, given the scale of the compounded GLP-1 phenomenon, he says
Another study of oncology trials conducted between 1994 and 2015 calculated the difference in the age of trial participants and the disease population they studied (Ludmir et al., 2019)